시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 불임용 줄기세포 치료 시장 보고서(2025년)
Stem Cell Therapy For Infertility Global Market Report 2025
상품코드 : 1889591
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,573,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,501,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,429,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

불임용 줄기세포 치료 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 16억 달러에서 2025년에는 18억 7,000만 달러에 달하고, CAGR 16.8%로 성장할 것으로 전망되고 있습니다. 지난 수년간의 성장은 남녀 모두의 불임 유병률 증가, 보조생식기술 기술에 대한 수요 증가, 줄기세포 기반 불임 치료에 대한 인지도 향상, 전문 불임 치료 클리닉의 확대, 재생 의료 접근법의 보급 확대 등이 요인으로 예상됩니다.

불임용 줄기세포 치료 시장 규모는 향후 수년간 빠른 성장이 예상됩니다. 2029년에는 34억 3,000만 달러에 달하고 CAGR은 16.5%을 나타낼 것으로 예측됩니다. 예측기간의 성장은 불임치료에 대한 정부 및 민간 부문의 지원 확대, 줄기세포 기반 요법의 임상적 성공률 향상, 생명공학기업과 불임치료센터 간의 협력 확대, 비침습적 불임치료 옵션에 대한 수요 증가, 줄기세포 응용을 통한 생식 결과 개선에 대한 주력 강화에 의해 견인될 전망입니다. 예측기간의 주요 동향으로는 유도 만능 줄기세포(iPS 세포)의 진보, 난소 줄기세포 기술의 진전, 자궁내막 재생요법의 혁신, 불임치료와 인공지능(AI)의 통합, 생식조직 복구를 위한 선진적인 생체재료 스캐폴드의 개발 등을 들 수 있습니다.

불임의 증례 증가는 앞으로 수년간 불임용 줄기세포 치료 시장의 성장에 크게 기여할 것으로 예측됩니다. 불임이란 12개월 이상 정기적으로 피임하지 않고 성교를 하여도 임신할 수 없는 상태를 말합니다. 불임의 증가 추세는 주로 출산시기 지연으로 인해 발생합니다. 많은 사람들이 삶의 후반기에 아이를 갖기로 선택하면서, 특히 여성의 노화와 관련된 생식 능력의 자연 감퇴로 인해 임신률이 하락하고 있습니다. 불임용 줄기세포 치료는 손상된 생식 조직의 재생, 난소 및 고환 기능의 강화, 임신 가능성의 향상을 통해 유망한 해결책을 제공합니다. 예를 들어, 2023년 4월 세계보건기구(WHO)가 발표한 보고서에 따르면 불임은 세계 성인 인구의 약 17.5%, 즉 약 6명 중 1명에 영향을 미쳤으며, 고품질의 불임 치료를 저렴한 가격에 제공할 필요성이 높아지고 있음을 강조하고 있습니다. 따라서 불임 사례 증가는 불임용 줄기세포 치료 시장의 확대를 촉진할 것으로 예측됩니다.

불임용 줄기세포 치료 시장의 주요 기업은 iPS세포(유도 만능 줄기세포) 등 줄기세포 기술의 진보에 주력하여 맞춤 재생의료 개선, 환자 고유의 치료 성과 향상, 치료 가능한 생식 질환의 범위 확대를 도모하고 있습니다. iPS 세포는 성체 세포를 유전자 조작에 의해 배아 만능 상태로 재프로그래밍한 것으로, 체내의 거의 모든 세포 유형으로 분화할 수 있습니다. 예를 들어, 2025년 1월에는 미국에 본사를 둔 생명공학 기업 Gameto Inc.가 미국 식품의약국(FDA)으로부터 임상시험신청(IND) 승인을 받아 회사의 iPS세포 유래 불임치료 "Fertilo"의 3상 임상시험을 시작했습니다. 본 시험은 미국 내 약 15개 시설에서 실시되어 유전자 조작을 실시한 난소 지지 세포를 이용한 체외 난자 성숙을 평가하는 것을 목적으로 하고 있습니다. 이 기술은 체외수정(IVF)(IVF) 사이클의 단축과 호르몬 자극량을 최대 80% 감소시킬 수 있습니다. 시험이 성공하면 불임 치료에서 iPS 세포 유래 체외 성숙 난자 요법을 대상으로 한 최초의 후기 임상 프로그램이 됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장의 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Stem cell therapy for infertility is an advanced regenerative treatment approach that uses stem cells to restore or enhance the function of reproductive tissues and organs in both males and females. It aims to repair damaged ovarian, testicular, or endometrial tissues, improve gamete quality, and support hormonal balance.

The primary components of stem cell therapy for infertility include male infertility treatment and female infertility treatment. Stem cell therapy for male infertility is a regenerative approach that uses stem cells to improve or restore sperm production and overall reproductive function in men experiencing reduced fertility. Treatment types include autologous stem cell therapy, allogeneic stem cell therapy, and combination therapy. Cell sources include embryonic stem cells, adult stem cells, and induced pluripotent stem cells. Applications include ovarian insufficiency, uterine infertility, and genetic disorders. Primary end users include hospitals, specialty clinics, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The stem cell therapy for infertility market research report is one of a series of new reports from The Business Research Company that provides stem cell therapy for infertility market statistics, including stem cell therapy for infertility industry global market size, regional shares, competitors with a stem cell therapy for infertility market share, detailed stem cell therapy for infertility market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy for infertility industry. This stem cell therapy for infertility market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell therapy for infertility market size has grown rapidly in recent years. It will grow from $1.60 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 16.8%. The growth in the historic period can be linked to the increasing prevalence of infertility among both men and women, rising demand for assisted reproductive technologies, growing awareness of stem-cell-based fertility treatments, the expansion of specialized fertility clinics, and greater adoption of regenerative medicine approaches.

The stem cell therapy for infertility market size is expected to see rapid growth in the next few years. It will grow to $3.43 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be driven by growing government and private sector support for fertility treatments, rising clinical success rates of stem-cell-based therapies, expanding collaborations between biotech companies and fertility centers, increasing demand for non-invasive fertility treatment options, and a stronger focus on improving reproductive outcomes through stem cell applications. Major trends in the forecast period include advancements in induced pluripotent stem cells, progress in ovarian stem cell techniques, innovations in endometrial regeneration therapy, integration of artificial intelligence in fertility treatments, and the development of advanced biomaterial scaffolds for repairing reproductive tissues.

The rising cases of infertility are expected to significantly contribute to the growth of the stem cell therapy market for infertility in the coming years. Infertility is defined as the inability of a couple to conceive after 12 months or more of regular unprotected sexual intercourse. The increasing prevalence of infertility is mainly due to delayed childbearing, as many individuals opt to have children later in life, leading to reduced fertility because of the natural decline in reproductive potential with age, particularly among women. Stem cell therapy for infertility offers promising solutions by regenerating damaged reproductive tissues, enhancing ovarian and testicular function, and improving the chances of conception. For instance, in April 2023, a report from the World Health Organization (WHO) indicated that infertility affects approximately 17.5% of the global adult population, or about 1 in 6 people, emphasizing the growing need to expand access to affordable, high-quality fertility care. Therefore, the increasing infertility cases are expected to drive the expansion of the stem cell therapy for infertility market.

Leading companies in the stem cell therapy for infertility market are focusing on advancements in stem cell technologies, such as induced pluripotent stem cells (iPSCs), to improve personalized regenerative treatments, enhance patient-specific outcomes, and widen the range of treatable reproductive conditions. Induced pluripotent stem cells are adult somatic cells that have been genetically reprogrammed to an embryonic-like pluripotent state, enabling them to differentiate into nearly any cell type in the body. For example, in January 2025, Gameto Inc., a U.S.-based biotechnology company, launched a pivotal Phase III clinical trial for its iPSC-derived fertility therapy, Fertilo, following Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA). The trial, which will take place across approximately 15 sites in the U.S., aims to assess egg maturation outside the body using engineered ovarian support cells, potentially shortening IVF cycles and reducing hormonal stimulation by up to 80%. If successful, this would be the first late-stage clinical program for in-vitro matured egg therapy derived from induced pluripotent stem cells in infertility treatment.

In October 2023, REPROCELL Inc., a biotechnology company based in Japan, acquired Gameto Inc. for an undisclosed amount. This acquisition aims to strengthen REPROCELL's position in the fertility and regenerative medicine sectors by integrating Gameto's advanced iPSC-based fertility technologies to accelerate the development of innovative infertility treatments. Gameto Inc. is a U.S.-based biotechnology company that specializes in stem cell therapy for infertility.

Major companies operating in the stem cell therapy for infertility market are PlacidWay LLC, New Life India Fertility Clinic Private Limited, Jeevan Mithra Fertility Centre Private Limited, Equipo IVI S.L., Hope Fertility & Stem Cell Centre Pvt. Ltd., Bioscience Institute SpA, Advancells Dermaceuticals Private Limited, GIOSTAR INDIA PRIVATE LIMITED, Shree IVF Clinic Private Limited, Stem Cells Care (india) Private Limited, GenCell Ltd., StemRx BioScience Solutions Private Limited., Kiran Infertility Centre Private Limited, R3 Stem Cell LLC., Bavishi Fertility Institute Private Limited, Seragen Biotherapeutics Private Limited, Esha IVF Fertility Centre Private Limited, Embryonic Tissue Center EmCell, InoCells B.V., Vega Stem Cell Clinic Co. Ltd.

North America was the largest region in the stem cell therapy for infertility market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in stem cell therapy for infertility report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the stem cell therapy for infertility market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stem cell therapy for infertility market includes revenues earned by providing services such as fertility restoration therapy services, clinical research support services, biobanking of stem cell services, allogeneic stem cell transplantation services, and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell Therapy For Infertility Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell therapy for infertility market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for stem cell therapy for infertility ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stem cell therapy for infertility market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Stem Cell Therapy For Infertility Market Characteristics

3. Stem Cell Therapy For Infertility Market Trends And Strategies

4. Stem Cell Therapy For Infertility Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Stem Cell Therapy For Infertility Growth Analysis And Strategic Analysis Framework

6. Stem Cell Therapy For Infertility Market Segmentation

7. Stem Cell Therapy For Infertility Market Regional And Country Analysis

8. Asia-Pacific Stem Cell Therapy For Infertility Market

9. China Stem Cell Therapy For Infertility Market

10. India Stem Cell Therapy For Infertility Market

11. Japan Stem Cell Therapy For Infertility Market

12. Australia Stem Cell Therapy For Infertility Market

13. Indonesia Stem Cell Therapy For Infertility Market

14. South Korea Stem Cell Therapy For Infertility Market

15. Western Europe Stem Cell Therapy For Infertility Market

16. UK Stem Cell Therapy For Infertility Market

17. Germany Stem Cell Therapy For Infertility Market

18. France Stem Cell Therapy For Infertility Market

19. Italy Stem Cell Therapy For Infertility Market

20. Spain Stem Cell Therapy For Infertility Market

21. Eastern Europe Stem Cell Therapy For Infertility Market

22. Russia Stem Cell Therapy For Infertility Market

23. North America Stem Cell Therapy For Infertility Market

24. USA Stem Cell Therapy For Infertility Market

25. Canada Stem Cell Therapy For Infertility Market

26. South America Stem Cell Therapy For Infertility Market

27. Brazil Stem Cell Therapy For Infertility Market

28. Middle East Stem Cell Therapy For Infertility Market

29. Africa Stem Cell Therapy For Infertility Market

30. Stem Cell Therapy For Infertility Market Competitive Landscape And Company Profiles

31. Stem Cell Therapy For Infertility Market Other Major And Innovative Companies

32. Global Stem Cell Therapy For Infertility Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stem Cell Therapy For Infertility Market

34. Recent Developments In The Stem Cell Therapy For Infertility Market

35. Stem Cell Therapy For Infertility Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기